New substituted quinazoline, quinoxaline, quinoline and isoquinoline compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.

 
Web www.patentalert.com

< Compositions for use as a signal generation component and methods of using same

> Diagnosis and treatment of disorders of iron metabolism

> Method of diagnosing tuberculosis

~ 00595